NCT00051116已完成2 期
A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 2
研究概览
简要总结
To evaluate the response rate, response duration, and survival of patients treated with CC-5013 in a chronic dosing schedule versus a syncopated dosing schedule.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal CancerColorectal CancerNCT00202774Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)348
已完成
2 期
Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaHead and Neck NeoplasmsNeoplasm Recurrence, LocalNeoplasm MetastasisNCT00401323Sanofi568
已完成
2 期
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation RelapseMultiple MyelomaNCT00083681University of Arkansas180
已完成
2 期
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)LeukemiaNCT00483067M.D. Anderson Cancer Center13
已完成
2 期
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System LymphomaLymphoma, Non-HodgkinHIV InfectionsNCT00000801National Institute of Allergy and Infectious Diseases (NIAID)33